Federal Register #DEA-1155

DEA Final Rule: Diphenidine Placed in Schedule I of the Controlled Substances Act

This notice announces a final rule by the Drug Enforcement Administration (DEA), under the Department of Justice, regarding the regulatory status of diphenidine. - Government Buyer: - Department of Justice (DOJ) - Drug Enforcement Administration (DEA) - No OEMs or commercial vendors are involved, as this is a regulatory action, not a procurement. - Products/Services Requested: - No products or services are being procured. - The rule pertains to the chemical substance diphenidine (1-(1,2-diphenylethyl)piperidine), including its salts, isomers, and salts of isomers. - Unique or Notable Requirements: - Diphenidine is permanently placed in Schedule I of the Controlled Substances Act. - All persons handling diphenidine must comply with Schedule I regulatory controls, including registration, security, labeling, quotas, inventory, records, order forms, import/export controls, and liability. - Action fulfills U.S. obligations under the 1971 Convention on Psychotropic Substances. - No purchase quantities, part numbers, or procurement actions are associated with this notice.

Description

The Drug Enforcement Administration (DEA) issues a final rule placing diphenidine, including its salts, isomers, and salts of isomers, in Schedule I of the Controlled Substances Act. This action is taken to meet U.S. obligations under the 1971 Convention on Psychotropic Substances and imposes regulatory controls and sanctions applicable to Schedule I substances on persons who handle or propose to handle diphenidine. The rule includes requirements for registration, security, labeling, quota, inventory, records, order forms, importation, exportation, and liability. The effective date of this rule is October 21, 2026.

View original listing